Come & Meet us on the Sebia booth #121
Location: ICM Internationales Congress Center, Munich
Sebia Workshop EduW22
WHAT’S NEW IN MINIMAL RESIDUAL DISEASE TESTING FOR MULTIPLE MYELOMA?
Date: Tuesday, April 12th
From 15:30 to 16:30
Evolution makes the difference.
The power of up to 36 capillaries in one automated high volume workcell.
Connect our flexible electrophoresis instrument on lab automation track.
Large menu with high quality results on gel electrophoresis.
The compact and affordable automation of Capillary Electrophoresis.
The high throughput solution for newborn hemoglobin disorders screening.
Any assay, any time!
For Customized Patient Profiles in
Autoimmune and Infectious Disease Diagnostics
The gold standard assay for the alpha 1-antitrypsin (A1AT) phenotype testing.
The most reliable chronic alcohol abuse marker.
The gold standard assay to objectively detect CNS local IgG synthesis in multiple sclerosis.
The next generation Free Light Chain Assay.
Uncompromized HbA1c Results.
The high-resolution method for hemoglobin disorders screening.
Avoid interferences due to therapeutic Monoclonal Antibody with HYDRASHIFT Portfolio.
Identification of monoclonal proteins by agarose gel electrophoresis.
Fully automated monoclonal proteins identification by Capillarys electrophoresis.
Proteinuria screening for renal disease.
High throughput Serum Protein Electrophoresis, with high resolution results.
High throughput Urine Protein Electrophoresis, with high resolution results.
Multimer assay simplified.
The perfect match for screening hemoglobin disorders in newborns.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.